Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2009 4
2011 3
2016 2
2017 1
2018 1
2019 2
2021 4
2022 8
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Burden of Influenza-Associated Respiratory Hospitalizations, Vietnam, 2014-2016.
Khanh NC, Fowlkes AL, Nghia ND, Duong TN, Tu NH, Tu TA, McFarland JW, Nguyen TTM, Ha NT, Gould PL, Thanh PN, Trang NTH, Mai VQ, Thi PN, Otsu S, Azziz-Baumgartner E, Anh DD, Iuliano AD. Khanh NC, et al. Among authors: fowlkes al. Emerg Infect Dis. 2021 Oct;27(10):2648-2657. doi: 10.3201/eid2710.204765. Emerg Infect Dis. 2021. PMID: 34545793 Free PMC article.
Live Attenuated and Inactivated Influenza Vaccine Effectiveness.
Chung JR, Flannery B, Ambrose CS, Bégué RE, Caspard H, DeMarcus L, Fowlkes AL, Kersellius G, Steffens A, Fry AM; Influenza Clinical Investigation for Children Study Team; Influenza Incidence Surveillance Project; US Influenza Vaccine Effectiveness Network. Chung JR, et al. Among authors: fowlkes al. Pediatrics. 2019 Feb;143(2):e20182094. doi: 10.1542/peds.2018-2094. Epub 2019 Jan 7. Pediatrics. 2019. PMID: 30617239 Free PMC article.
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
Thompson MG, Burgess JL, Naleway AL, Tyner H, Yoon SK, Meece J, Olsho LEW, Caban-Martinez AJ, Fowlkes AL, Lutrick K, Groom HC, Dunnigan K, Odean MJ, Hegmann K, Stefanski E, Edwards LJ, Schaefer-Solle N, Grant L, Ellingson K, Kuntz JL, Zunie T, Thiese MS, Ivacic L, Wesley MG, Mayo Lamberte J, Sun X, Smith ME, Phillips AL, Groover KD, Yoo YM, Gerald J, Brown RT, Herring MK, Joseph G, Beitel S, Morrill TC, Mak J, Rivers P, Poe BP, Lynch B, Zhou Y, Zhang J, Kelleher A, Li Y, Dickerson M, Hanson E, Guenther K, Tong S, Bateman A, Reisdorf E, Barnes J, Azziz-Baumgartner E, Hunt DR, Arvay ML, Kutty P, Fry AM, Gaglani M. Thompson MG, et al. Among authors: fowlkes al. N Engl J Med. 2021 Jul 22;385(4):320-329. doi: 10.1056/NEJMoa2107058. Epub 2021 Jun 30. N Engl J Med. 2021. PMID: 34192428 Free PMC article.
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers.
Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S. Lutrick K, et al. Among authors: fowlkes al. Vaccine. 2022 Jan 24;40(3):494-502. doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11. Vaccine. 2022. PMID: 34906392 Free PMC article.
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers.
Yoon SK, Hegmann KT, Thiese MS, Burgess JL, Ellingson K, Lutrick K, Olsho LEW, Edwards LJ, Sokol B, Caban-Martinez AJ, Schaefer-Solle N, Jones JM, Tyner H, Hunt A, Respet K, Gaglani M, Dunnigan K, Rose S, Naleway A, Groom H, Kuntz J, Fowlkes AL, Thompson MG, Yoo YM; HEROES-RECOVER Network Investigators; HEROES-RECOVER Network Investigators. Yoon SK, et al. Among authors: fowlkes al. N Engl J Med. 2022 May 12;386(19):1855-1857. doi: 10.1056/NEJMc2201821. Epub 2022 Apr 6. N Engl J Med. 2022. PMID: 35385628 Free PMC article. No abstract available.
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers.
Ellingson KD, Hollister J, Porter CJ, Khan SM, Feldstein LR, Naleway AL, Gaglani M, Caban-Martinez AJ, Tyner HL, Lowe AA, Olsho LEW, Meece J, Yoon SK, Mak J, Kuntz JL, Solle NS, Respet K, Baccam Z, Wesley MG, Thiese MS, Yoo YM, Odean MJ, Miiro FN, Pickett SL, Phillips AL, Grant L, Romine JK, Herring MK, Hegmann KT, Lamberte JM, Sokol B, Jovel KS, Thompson MG, Rivers P, Pilishvili T, Lutrick K, Burgess JL, Midgley CM, Fowlkes AL. Ellingson KD, et al. Among authors: fowlkes al. Emerg Infect Dis. 2023 Mar;29(3):599-604. doi: 10.3201/eid2903.221314. Epub 2023 Jan 26. Emerg Infect Dis. 2023. PMID: 36703252 Free PMC article.
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection.
Tyner HL, Burgess JL, Grant L, Gaglani M, Kuntz JL, Naleway AL, Thornburg NJ, Caban-Martinez AJ, Yoon SK, Herring MK, Beitel SC, Blanton L, Nikolich-Zugich J, Thiese MS, Pleasants JF, Fowlkes AL, Lutrick K, Dunnigan K, Yoo YM, Rose S, Groom H, Meece J, Wesley MG, Schaefer-Solle N, Louzado-Feliciano P, Edwards LJ, Olsho LEW, Thompson MG. Tyner HL, et al. Among authors: fowlkes al. Clin Infect Dis. 2022 Aug 24;75(1):e827-e837. doi: 10.1093/cid/ciab1038. Clin Infect Dis. 2022. PMID: 34928334 Free PMC article.
Detection and Stability of SARS-CoV-2 in Three Self-Collected Specimen Types: Flocked Midturbinate Swab (MTS) in Viral Transport Media, Foam MTS, and Saliva.
Veguilla V, Fowlkes AL, Bissonnette A, Beitel S, Gaglani M, Porucznik CA, Stockwell MS, Tyner HL, Naleway AL, Yoon SK, Caban-Martinez AJ, Wesley MG, Duque J, Jeddy Z, Stanford JB, Daugherty M, Dixon A, Burgess JL, Odean M, Groom HC, Phillips AL, Schaefer-Solle N, Mistry P, Rolfes MA, Thompson M, Dawood FS, Meece J. Veguilla V, et al. Among authors: fowlkes al. Microbiol Spectr. 2022 Jun 29;10(3):e0103322. doi: 10.1128/spectrum.01033-22. Epub 2022 Jun 6. Microbiol Spectr. 2022. PMID: 35665629 Free PMC article.
Incidence of SARS-CoV-2 infection among COVID-19 vaccinated and unvaccinated healthcare personnel, first responders, and other essential and frontline workers: Eight US locations, January-September 2021.
Naleway AL, Grant L, Caban-Martinez AJ, Wesley MG, Burgess JL, Groover K, Gaglani M, Yoon SK, Tyner HL, Meece J, Kuntz JL, Yoo YM, Schaefer-Solle N, Olsho LEW, Gerald JK, Rose S, Thiese MS, Lundgren J, Groom HC, Mak J, Louzado Feliciano P, Edwards LJ, Lutrick K, Dunnigan K, Phillips AL, Lamberte JM, Noriega R, Sokol BE, Odean M, Ellingson KD, Smith M, Hegmann KT, Respet K, Dickerson M, Cruz A, Fleary DE, Murthy K, Hunt A, Azziz-Baumgartner E, Gallimore-Wilson D, Harder JA, Odame-Bamfo L, Viergutz J, Arvay M, Jones JM, Mistry P, Thompson MG, Fowlkes AL. Naleway AL, et al. Among authors: fowlkes al. Influenza Other Respir Viruses. 2022 May;16(3):585-593. doi: 10.1111/irv.12956. Epub 2022 Jan 13. Influenza Other Respir Viruses. 2022. PMID: 35023288 Free PMC article.
Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023.
Fowlkes AL, Nogareda F, Regan A, Loayza S, Mancio JM, Duca LM, Couto P, Leite J, Rodriguez A, Salas D, Azziz-Baumgartner E; REVELAC–i Network. Fowlkes AL, et al. MMWR Morb Mortal Wkly Rep. 2023 Sep 15;72(37):1010-1015. doi: 10.15585/mmwr.mm7237e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37708084 Free PMC article. No abstract available.
35 results